Jianping Wu

Title: Innovations of Jianping Wu

Introduction

Jianping Wu is a notable inventor based in Anhui, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical health issues. With a total of 2 patents, his work is paving the way for advancements in drug development.

Latest Patents

Wu's latest patents include a groundbreaking invention related to a 2,4,6-trisubstituted s-triazine compound. This compound is represented by a general formula and includes pharmaceutically acceptable salts, prodrugs, or solvates. The preparation method and use of these compounds are aimed at creating drugs that prevent or treat diseases associated with protein kinase and vimentin dysregulation, as well as cell vacuolization. Notably, these drugs are particularly focused on treating or preventing cancer growth and metastasis, tissue fibrosis, and atherosclerosis.

Career Highlights

Jianping Wu is currently associated with Aluda Pharmaceuticals, Inc., where he continues to innovate and contribute to the pharmaceutical industry. His expertise and research are instrumental in developing new therapeutic solutions.

Collaborations

Wu collaborates with talented individuals in his field, including Qizheng Yao and Ruihuan Chen, who contribute to his research endeavors.

Conclusion

Jianping Wu's innovative work in the pharmaceutical sector highlights the importance of research and development in addressing critical health challenges. His contributions are significant in the ongoing fight against diseases, particularly cancer and related conditions.